Clinical Trial Services

Jun 16

Exciting Times at ESHG 2024 in Berlin

The Edinburgh Genetics team was thrilled to be part of the European Society of Human Genetics (ESHG) 2024 conference in Berlin in June...

Apr 3

Next-generation sequencing role in pharmacogenetics and pharmacogenomics

Next-generation sequencing (NGS) represents an efficient and reliable method to evaluate the contribution of both common and rare...

Mar 31

Working with the University of Gdansk in a landmark HTAD Treatment Trial

Marfan syndrome is a genetic disorder that affects the body's connective tissue, which provides strength, support, and elasticity to...

Sep 13, 2023

The link between proteogenomics and the advancement in precision medicine

The emerging discipline of proteogenomics arose from the combination of two molecular biology fields – mass spectrometry (MS)-based...

Aug 27, 2022

Genome-first approach to mendelian cardiovascular disease

Since the 1990s cardiovascular genomics has been a popular area of research, heading toward a genome-first approach to the diagnosis and...

Aug 27, 2022

Uncovering variants by utilising WES on HIV-positive population in Botswana

Although Africa is a genetically diverse continent there has not been extensive genetic disease mapping of the continent as there has...

Aug 23, 2022

Chemotherapy, radiotherapy and adverse drug reaction mitigation using NGS

Chemotherapy is often aggressive and can provoke severe toxicity and adverse drug reactions (ADR). Noticeable differences also exist in...

Aug 23, 2022

The role of egSEQ Exome in the research and diagnosis of Parkinson’s diseases

Neurology researchers are utilising our market-leading egSEQ library preparation and Exome solutions to understand genetic risk factors...

Aug 22, 2022

Access to genetic testing and the role of effective genetic counselling

Although it is widely accepted that genetic testing is an important tool to aid early diagnosis in some patient cohorts, studies have...

Aug 22, 2022

NGS testing for CYP gene and variation in drug responses

Among the most researched pharmacogenes is the CYP gene superfamily (Fukunaga et al., 2021), which influences drug-metabolising enzymes...

Aug 22, 2022

Oncology targeted therapy with egSEQ NGS

Personalised diagnostic and precision medicine for cancer patients involves tailoring each patient’s treatment based on the genomic...

Aug 22, 2022

Recurrence monitoring of colorectal and breast cancer patients with egSEQ Comprehensive Solid Tumour

With the continuous discovery of genetic targets correlated with recurrence risk, time to recurrence (TTC) and/or overall survival, it is...